BIOLASE, Inc. Announces Departure of Todd Norbe as Chief Executive Officer
March 17, 2021 at 04:16 pm
Share
On February 23, 2021, Biolase, Inc. announced the departure of Todd Norbe from the Company and his positions as Chief Executive Officer effective immediately. On March 12, 2021, the Company entered into a Separation Agreement With General Release of All Claims with Mr. Norbe (the Separation Agreement).
BIOLASE, Inc. is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company's systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. The Company's all-tissue Waterlase dental laser systems consist of its flagship Waterlase iPlus, Waterlase Express, and Waterlase MDX. Its soft tissue diode laser systems consist of the Epic X, Epic Hygiene, Epic Q, and Epic 10 diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief. Epic X, and Epic 10 systems feature its 940 nanometer wavelength with patented pulse technology called ComfortPulse.
BIOLASE, INC. 
